Lexington, KY 的 卵巢癌 臨床試驗
16 項針對 卵巢癌 的研究正在 Lexington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
招募中2 期
- Baptist Health Lexington /ID# 275218, Lexington
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
招募中2 期
- Baptist Health Lexington /ID# 278267, Lexington
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
招募中2/3 期
- University of Kentucky/Markey Cancer Center, Lexington
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
招募中3 期
- Baptist Health Lexington, Lexington
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Baptist Health Lexington, Lexington
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- 還有 1 項
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
招募中
- Baptist Health Lexington, Lexington
Lead-212 PSV359 Therapy for Patients With Solid Tumors
招募中1/2 期
- University of Kentucky, Lexington
EXoPERT EMERALD Clinical Study
招募中觀察性研究歡迎健康志工
- Lexington VA Healthcare System, Lexington
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
招募中2 期
- Baptist Health Lexington /ID# 272211, Lexington
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
招募中3 期
- University of Kentucky Medical Center, Lexington
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
招募中2 期
- University of Kentucky, Lexington
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
招募中1 期
- University of Kentucky Medical Center, Lexington
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- University of Kentucky Markey Cancer Center, Lexington
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
招募中觀察性研究歡迎健康志工
- Baptist Lexington, Lexington
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
招募中歡迎健康志工
- Markey Cancer Center, Lexington
其他城市的 卵巢癌 試驗
- Houston, TX89 項研究
- New York City, NY70 項研究
- Boston, MA61 項研究
- Los Angeles, CA50 項研究
- Nashville, TN49 項研究
- Arlington, VA46 項研究
- Philadelphia, PA45 項研究
- Columbus, OH39 項研究
- St. Louis, MO38 項研究
- Chicago, IL36 項研究
- Pittsburgh, PA31 項研究
- San Antonio, TX31 項研究
Lexington 的其他研究
- 非小細胞肺癌23 項研究
- 肺癌18 項研究
- 癌症（所有類型）14 項研究
- 乳癌14 項研究
- 前列腺癌14 項研究
- 轉移性癌症11 項研究
- 大腸直腸癌11 項研究
- 心臟衰竭11 項研究
- 急性髓系白血病10 項研究
- 肥胖症10 項研究
- 黑色素瘤10 項研究
- 頭頸部鱗狀細胞癌9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月7日。各研究自行設定資格標準；由研究團隊決定參與者資格。